Dr. Jonathan Abraham's lab at Harvard Medical School studies alphaviruses, which are mosquito-borne viruses that can lead to severe brain infections. The lab focuses on understanding the cellular receptors these viruses use to infect brain cells and exploring potential therapeutic approaches to prevent infections. By using advanced techniques like cryo-electron microscopy, the lab aims to visualize virus-receptor interactions and develop strategies to combat these dangerous pathogens.

The lab of David E Reich at Harvard Medical School focuses on utilizing ancient DNA to enhance our understanding of human genetic traits and disease risk over time. By analyzing large datasets from various historical populations, the lab aims to uncover how evolutionary forces have shaped genetic variation and complex traits in humans. This research not only provides insights into our past but also helps make connections to present-day health issues and genetic diversity.

Lisa Goodrich's lab at Harvard Medical School studies how specialized cells in the cochlea, particularly glia and neurons, interact to support hearing throughout life. Her team investigates the genetic and molecular mechanisms behind these interactions and how they may be disrupted in conditions leading to hearing loss. By exploring these relationships, they aim to uncover methods to promote recovery from cochlear damage and better understand auditory function.

Dr. Diane J Mathis's lab at Harvard Medical School studies the mechanisms of autoimmune diseases, which affect a significant portion of the population. The lab focuses on understanding how certain cells in the thymus, called medullary thymic epithelial cells (mTECs), help T cells learn to tolerate the body's own antigens, preventing autoimmune reactions. They recently discovered a new type of thymic cell that could play a crucial role in this tolerance process. This research aims to uncover the molecular interactions that help generate these cells and understand their significance in preventing autoimmune diseases.

The research lab led by Dr. Ethan Clark Garner at Harvard focuses on understanding the molecular mechanisms of bacterial cell division, specifically how proteins called FtsZ and FtsA deform the bacterial membrane to initiate this process. By studying these mechanisms, the lab aims to improve our understanding of antibiotic design and how to combat pathogenic bacteria more effectively. Their work combines in vivo experiments with in vitro studies to explore the physical properties and behaviors of these filaments at the cellular level.

Dr. Suzanne Walker's lab at Harvard Medical School focuses on understanding bacterial cell envelopes and their roles in antibiotic resistance. The team investigates how bacteria maintain their structural integrity and how this knowledge can aid in developing new antibiotics. By exploring the molecular mechanisms behind cell envelope biogenesis, the lab aims to identify new therapeutic targets to combat resistant bacterial infections.

Dr. Paola Arlotta's lab at Harvard University focuses on understanding how the brain develops, particularly in relation to neurodevelopmental disorders like autism. They use advanced techniques to create models of the human brain using organoids, which are miniature, simplified versions of the brain. By studying these organoids, the lab investigates how specific genetic mutations affect neuron development and brain circuits, aiming to uncover the underlying causes of autism spectrum disorder (ASD).

The Brown lab at Harvard Medical School focuses on understanding how tiny structures called cilia and flagella function in various organisms, including humans and parasites. Their research explores the molecular mechanisms that control the movement of these structures, which play crucial roles in processes like fertility and disease. By using cutting-edge techniques, they hope to uncover how these movements are regulated and how this knowledge can lead to new treatments for diseases caused by parasites that affect millions of people.

Stephen Buratowski's lab at Harvard Medical School focuses on understanding the intricate processes of gene expression by examining how RNA polymerase II, an enzyme responsible for transcribing DNA into RNA, is regulated. The lab investigates the role of various protein modifications and interactions during transcription, which has significant implications for diseases such as cancer and viral infections like HIV. By utilizing cutting-edge techniques like mass spectrometry and single-molecule microscopy, they aim to uncover dynamic events that govern gene expression, potentially leading to new therapeutic strategies.

Dr. Eric N. Jacobsen's lab focuses on developing new methods for catalytic reactions that select for specific molecular structures, which is critical for creating complex organic molecules used in pharmaceuticals and other applications. The research aims to design small organic catalysts that are both effective and environmentally friendly, enabling efficient synthesis of chiral compounds important for public health. This work blends creativity in catalyst design with rigorous scientific investigation to solve complex challenges in organic chemistry.

Dr. Tom A. Rapoport's lab focuses on understanding how proteins are transported across cellular membranes, particularly from the endoplasmic reticulum (ER) to other parts of the cell, or to be degraded. The lab investigates processes like misfolded protein degradation and how proteins are imported into organelles such as peroxisomes. Their research is crucial for addressing diseases linked to protein misfolding, like cystic fibrosis and Zellweger syndrome, and aims to uncover new therapeutic approaches.

Dr. Stephen C. Blacklow's lab at Harvard Medical School focuses on understanding the molecular mechanisms of cellular signaling, particularly through Notch signaling and tetraspanin proteins. They employ advanced technologies to visualize how signals are transmitted within cells, which is important for understanding diseases like cancer and immune disorders. The lab's research aims to pave the way for future therapeutic strategies by elucidating the roles of these signaling pathways in both normal physiology and disease states.

Dr. Xihong Lin's lab focuses on using advanced statistical and machine learning techniques to analyze large genetic and genomic datasets in cancer research. They aim to uncover insights into cancer prevention and treatment by integrating various types of data, such as whole genome sequencing, single-cell omics, and clinical information. The lab is committed to reducing health disparities through precision medicine strategies by developing accessible tools for the cancer research community.

Dr. Michael Starnbach's lab at Harvard Medical School focuses on understanding how the immune system, specifically CD8+ T cells, responds to infections caused by the bacterium Chlamydia trachomatis. The lab aims to uncover why these T cells are unable to form long-lasting memory after primary infection, which leads to repeated infections and potential infertility in affected individuals. Their research also explores new vaccine strategies to enhance immune response and protection against this significant public health issue.

John Joseph Mekalanos's lab at Harvard Medical School focuses on understanding the pathogenic mechanisms of Vibrio cholerae, the bacteria responsible for cholera. Their research explores how this pathogen interacts with the host immune system, commensal organisms, and viral agents. They also work on developing innovative vaccines and therapeutic approaches that could have far-reaching implications for public health and microbial immunology.

Dr. Nancy Kleckner's lab at Harvard University studies how chromosomes behave and organize themselves during important processes like cell division and reproduction. By examining both yeast and E. coli, the team explores the similarities between meiotic (sexual reproduction) and mitotic (cell division) chromosomes, looking for common patterns and mechanisms. Their work has implications for understanding infertility, cancer, and antibiotic resistance.

Dr. David P. Corey’s lab at Harvard Medical School focuses on understanding and developing therapies for hearing and balance disorders. The lab works on innovative gene therapy techniques to treat hereditary deafness, specifically targeting genetic mutations that cause hearing loss. In addition, they study the fundamental processes of auditory transduction — how sound is converted into electrical signals in the ear, with the ultimate goal of improving treatments for patients with hearing impairments.

Dr. Gordon J. Fishell's lab at Harvard Medical School focuses on understanding the development of cortical interneurons, specifically those expressing somatostatin (SST) and parvalbumin (PV). They aim to unravel how diverse these interneurons are and how genetic regulation and signals from neighboring cells shape their development and function, contributing to circuit formation in the brain. This research holds significance for understanding how disruptions in these processes can lead to brain diseases.

Dr. Jennifer Oyler-Yaniv's lab at Harvard Medical School studies how immune signals, specifically cytokines produced by T-cells, spread through tissues and influence immune responses. By exploring the limited range of these signals, the lab aims to understand how local differences in cytokine availability can lead to variations in gene expression and immune cell behavior. This research is important for developing better strategies for immunotherapy and other treatments that rely on understanding immune dynamics in complex environments.

Dr. Joseph J. Loparo's research lab at Harvard Medical School focuses on understanding how cells repair damaged DNA, specifically through a process called non-homologous end joining (NHEJ). This repair mechanism is crucial for maintaining genomic integrity, and understanding it can have implications for cancer treatment and gene therapy. By using advanced imaging techniques, the lab investigates the molecular details of how DNA ends are fixed and how errors can occur during this process, leading to potential diseases.